EVP, President, CDGCIK 0002024911
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Engelhardt Eva AnetteEVP, President, CDG |  BIOBIO.BBIO-RAD LABORATORIES, INC.Option exercise | M | — 1,152 sh | Sep 9, 2026 traded Sep 6, 2026 | |
Engelhardt Eva AnetteEVP, President, CDG |
| BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise |
| M |
| — 1,027 sh |
| Sep 9, 2026 traded Sep 5, 2026 |
| 22 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $142K 369 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 23 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 1,152 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 22 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $187K 485 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 11 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Grant or award | A | — 4,313 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 1,027 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 36 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Open-market sale | SELL | $136K 550 sh | May 13, 2026 traded May 11, 2026 |